2,471
Views
2
CrossRef citations to date
0
Altmetric
Health Policy

Impact of reimbursement restriction on drug market sales under the National Health Insurance in Japan

ORCID Icon & ORCID Icon
Pages 206-211 | Received 29 Nov 2021, Accepted 19 Jan 2022, Published online: 09 Feb 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.